Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLC ?5.5mm WB, SLActive? 12mm RXD: medical device reports filed with FDA

436 reports name it, 2024–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

436
device reports naming the brand
0% of all MAUDE reports · about 210 a year
268
reports, 12 months to August 2026
153 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 436 reports that name the brand "BLC ?5.5mm WB, SLActive? 12mm RXD" (endosseous dental implant), received between June 2024 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

268 reports arrived in the 12 months to August 2026, up 75% from 153 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (58%), loss of osseointegration (6%) and difficult to insert (2.1%). The patient problems coded most often are fibrosis, pain and hyperresponsive to stimuli. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02142Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 6Jul 2024: 0Aug 2024: 9Sep 2024: 3Oct 2024: 4Nov 2024: 23Dec 2024: 122025Jan 2025: 15Feb 2025: 12Mar 2025: 6Apr 2025: 6May 2025: 0Jun 2025: 42Jul 2025: 15Aug 2025: 15Sep 2025: 21Oct 2025: 18Nov 2025: 23Dec 2025: 302026Jan 2026: 16Feb 2026: 25Mar 2026: 20Apr 2026: 21May 2026: 24Jun 2026: 19Jul 2026: 13Aug 2026: 38

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01022032024: 5720242025: 20320252026: 1762026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%436
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report52.1%227
Voluntary report0%0
User facility report0%0
Distributor report47.9%209
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate25358%62.8%
Loss of osseointegration266%22.4%
Difficult to insertthe device was hard to insert92.1%0.4%
Fracturea broken bone30.7%1.6%
Separation failure30.7%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis13029.8%
Painpain, site not specified6414.7%
Hyperresponsive to stimuli163.7%
Swelling/ edema143.2%
Inflammationinflammation102.3%
Hemorrhage/blood loss/bleeding92.1%
Numbnessnumbness81.8%
Abscessa collection of pus51.1%
Fistula40.9%
Hypersensitivity/allergic reaction20.5%
Sinus perforation20.5%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLC ?5.5mm WB, SLActive? 12mm RXDProduct code DZEAll MAUDE reports
Reports4363,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer52.1%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLC ?5.5mm WB, SLActive? 12mm RXD reports

How many FDA reports name BLC ?5.5mm WB, SLActive? 12mm RXD?

436 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 268 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (58%), loss of osseointegration (6%), difficult to insert (2.1%), fracture (0.7%) and separation failure (0.7%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (52.1%) and distributor reports (47.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLC ?5.5mm WB, SLActive? 12mm RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.